NVCT - Nuvectis Pharma - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

213.1M

Cash

24.6M

Avg Qtr Burn

-4.20M

Short % of Float

4.08%

Insider Ownership

60.34%

Institutional Own.

15.00%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
NXP800 Details Ovarian cancer, Cancer	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
NXP900 Details Cancer, Squamous cancers, Solid tumor/s	Phase 1a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.